Biomarkers for the differentiation of sepsis and SIRS: The need for the standardisation of diagnostic studies

Irish Journal of Medical Science

Volumn 180, Issue 4, 2011, Pages 793-798

  Hall, T C ^a   Bilku, D K ^a   Al Leswas, D ^a   Horst, C ^b   Dennison, A R ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Biomarkers; Sepsis; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRONECTIN; GELSOLIN; LEPTIN; OSTEOPONTIN; PENTRAXIN 3; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

CLINICAL ASSESSMENT; CLINICAL PRACTICE; GOLD STANDARD; HUMAN; IMMUNE RESPONSE; MORTALITY; NEUTROPHIL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; REGULATORY T LYMPHOCYTE; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; DIAGNOSIS, DIFFERENTIAL; HUMANS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 82955187756     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-011-0741-1     Document Type: Review

References (52)

1. JL Vincent Y Sakr CL Sprung, et al. 2006 Sepsis in European intensive care units: results of the SOAP study Crit Care Med 34 2 344 353 16424713 10.1097/01.CCM.0000194725.48928.3A (Pubitemid 43145611)
2. DA Harrison CA Welch JM Eddleston 2006 The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database Crit Care 10 2 R42 16542492 10.1186/cc4854 (Pubitemid 47086800)
3. RP Dellinger MM Levy JM Carlet, et al. 2008 Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock Intensive Care Med 34 17 60 18058085 10.1007/s00134-007-0934-2
4. MM Levy RP Dellinger SR Townsend, et al. 2010 Surviving Sepsis Campaign: the surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis Crit Care Med. 38 367 374 20035219 10.1097/CCM.0b013e3181cb0cdc
5. A Lever I Mackenzie 2007 Sepsis: definition, epidemiology, and diagnosis BMJ 335 879 883 17962288 10.1136/bmj.39346.495880.AE 1:CAS:528: DC%2BD2sXhtlOltrvI (Pubitemid 350069465)
6. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
7. JL Vincent 1997 Dear SIRS, Im sorry to say that I don't like you Crit Care Med 25 2 372 374 9034279 10.1097/00003246-199702000-00029 1:STN:280:DyaK2s7os1KlsQ%3D%3D (Pubitemid 27086078)
8. AW Bossink J Groeneveld CE Hack LG Thijs 1998 Prediction of mortality in febrile medical patients: how useful are systemic inflammatory response syndrome and sepsis criteria? Chest 113 6 1533 1541 9631790 10.1378/chest.113.6.1533 1:STN:280:DyaK1c3ptlGmsw%3D%3D (Pubitemid 28307156)
9. PA Pizzo 1989 Evaluation of fever in the patient with cancer Eur J Cancer Clin Oncol 25 Suppl 2 S9 S16 2693112
10. B Muller KL Becker H Schachinger, et al. 2000 Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit Crit Care Med 28 977 983 10809269 10.1097/00003246-200004000-00011 1:STN:280:DC%2BD3c3mslaltA%3D%3D (Pubitemid 30262065)
11. Young LS (1990) Gram-negative sepsis. In: Mandell GL, Douglas RDJ, Bennett JE (eds) Principles and practice of infectious diseases, pp 611-636 Churchill Livingstone, New York
12. L Leibovici I Shagra M Drucker H Konigsberger Z Samra SD Pitlik 1998 The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infections J Intern Med 244 379 386 9845853 10.1046/j.1365-2796. 1998.00379.x 1:CAS:528:DyaK1cXnvFShtLc%3D (Pubitemid 28513125)
13. M Zambon M Ceola R Almeida-de-Castro A Gullo JL Vincent 2008 Implementation of the surviving sepsis campaign guidelines for severe sepsis and septic shock: we could go faster J Crit Care 23 455 460 19056006 10.1016/j.jcrc.2007.08.003
14. RP Dellinger MM Levy JM Carlet, et al. 2008 Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 296 327 18158437 10.1097/01.CCM.0000298158.12101.41
15. E Mylonakis ET Ryan SB Calderwood 2001 Clostridium difficile-associated diarrhea: a review Arch Intern Med 161 4 525 533 11252111 10.1001/archinte.161. 4.525 1:STN:280:DC%2BD3M3jsVagsg%3D%3D (Pubitemid 32167517)
16. Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14(1):R15 (epub 2010)
17. DD Cicarelli JE Vieira FE Benseñor 2009 C-reactive protein is not a useful indicator for infection in surgical intensive care units Sao Paulo Med J 127 6 350 354 20512289 10.1590/S1516-31802009000600006
18. A Bouchon F Facchetti MA Weigand M Colonna 2001 TREM-1 amplifies inflammation and is a crucial mediator of septic shock Nature 410 1103 1107 11323674 10.1038/35074114 1:CAS:528:DC%2BD3MXjsVCrsbg%3D (Pubitemid 32391042)
19. S Gibot MN Kolopp-Sarda MC Bene, et al. 2004 Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis Ann Intern Med 141 9 15 15238365 1:CAS:528: DC%2BD2cXmtVKqsbY%3D
20. R Liao Z Liu S Wei F Xu Z Chen J Gong 2009 Triggering receptor in myeloid cells (TREM-1) specific expression in peripheral blood mononuclear cells of sepsis patients with acute cholangitis Inflammation 32 3 182 190 19396532 10.1007/s10753-009-9119-1 1:CAS:528:DC%2BD1MXlvV2gsr0%3D
21. C Bopp S Hofer A Bouchon JB Zimmermann E Martin MA Weigand 2009 Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation Eur J Anaesthesiol 26 6 504 507 19307971 10.1097/EJA. 0b013e328329afca 1:CAS:528:DC%2BD1MXntVGmsb8%3D
22. M Barati FR Bashar R Shahrami MH Zadeh MT Taher M Nojomi 2010 Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis J Crit Care 25 2 362.e1 362.e6 10.1016/j.jcrc.2009.10.004 1:CAS:528: DC%2BC3cXovFOgsLg%3D
23. S Stöve T Welte TO Wagner, et al. 1996 Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome Clin Diagn Lab Immunol 3 2 175 183 8991632 (Pubitemid 26103753)
24. O Selberg H Hecker M Martin A Klos W Bautsch J Köhl 2000 Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6 Crit Care Med 28 8 2793 2798 10966252 10.1097/00003246-200008000-00019 1:CAS:528:DC%2BD3MXjvVeqtLw%3D
25. MJ Ruiz-Alvarez S García-Valdecasas R De Pablo, et al. 2009 Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis J Intensive Care Med 24 1 63 71 19054806 10.1177/0885066608327095 1:STN:280:DC%2BD1M%2FntlOitg%3D%3D
26. K Abidi I Khoudri J Belayachi, et al. 2008 Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units Crit Care 12 2 R59 18435836 10.1186/cc6883 (Pubitemid 351716007)
27. H Wang B Cheng Q Chen, et al. 2008 Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients Crit Care 12 4 R106 18706105 10.1186/cc6988
28. CJ Cummings CN Sessler LD Beall BJ Fisher AM Best AA Fowler 1997 Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction Am J Respir Crit Care Med 156 2 Pt 1 431 437 9279220 1:STN:280:DyaK2svisFWksg%3D%3D (Pubitemid 27351975)
29. C Punyadeera EM Schneider D Schaffer, et al. 2010 A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity J Emerg Trauma Shock 3 1 26 35 20165718 10.4103/0974-2700.58666
30. R Vaschetto S Nicola C Olivieri, et al. 2008 Serum levels of osteopontin are increased in SIRS and sepsis Intensive Care Med 34 12 2176 2184 18807011 10.1007/s00134-008-1268-4 1:CAS:528:DC%2BD1MXnsVOjsw%3D%3D
31. N Hattori S Oda T Sadahiro, et al. 2009 YKL-40 identified by proteomic analysis as a biomarker of sepsis Shock 32 4 393 400 19197227 10.1097/SHK.0b013e31819e2c0c 1:CAS:528:DC%2BD1MXhtFanu7zJ
32. B Muller G Peri A Doni, et al. 2001 Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients Crit Care Med 29 7 1404 1407 11445697 10.1097/00003246-200107000-00017 1:CAS:528:DC%2BD3MXnt1Smt7o%3D (Pubitemid 32641804)
33. BK Al-Ramadi M Ellis F Pasqualini A Mantovani 2004 Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancy Clin Immunol 112 3 221 224 15308113 10.1016/j.clim.2004.03.012 1:CAS:528:DC%2BD2cXmslOhu7Y%3D (Pubitemid 39078695)
34. Hofer S, Brenner T, Bopp C et al (2009) Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 13(3):R93
35. Wang JF, Yu ML, Yu G et al (2010) Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 394(1):184-188
36. AA Yousef YM Amr GA Suliman 2010 The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study Crit Care 14 2 R33 20230641 10.1186/cc8911
37. G Ruiz Martín J Prieto Prieto J Veiga de Cabo, et al. 2004 Plasma fibronectin as a marker of sepsis Int J Infect Dis 8 4 236 243 15234328 10.1016/j.ijid.2003.10.005 (Pubitemid 38953679)
38. + regulatory T cells and plasma levels of soluble CD25 Tokoku J Exp Med 216 61 68 10.1620/tjem.216.61 1:CAS:528:DC%2BD1cXhtFOms7bI
39. Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, Bollaert PE (2010) The relationship between CD4+CD25+CD127-regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14(1):R19
40. RT Cursons E Jeyerajah JW Sleigh 1999 The use of polymerase chain reaction to detect septicemia in critically ill patients Crit Care Med 27 937 940 10362416 10.1097/00003246-199905000-00029 1:STN:280:DyaK1M3ovFalsA%3D%3D (Pubitemid 29266011)
41. PM Dark P Dean G Washurst 2009 Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection Crit Care 13 4 217 19664174 10.1186/cc7886
42. RF Louie Z Tang TE Albertson S Cohen NK Tran GJ Kost 2008 Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia Crit Care Med 36 1487 1492 18434904 10.1097/CCM.0b013e31816f487c 1:CAS:528: DC%2BD1cXltlSgtr4%3D (Pubitemid 351620647)
43. B Clyne JS Olshaker 1999 The C-reactive protein J Emerg Med 17 1019 1025 10595891 10.1016/S0736-4679(99)00135-3 1:STN:280:DC%2BD3c%2FmtFensg%3D%3D (Pubitemid 29528076)
44. F Jaimes C Arango G Ruiz, et al. 2004 Predicting bacteremia at the bedside Clin Infect Dis 38 357 362 14727205 10.1086/380967 (Pubitemid 38200111)
45. P Povoa E Almeida P Moreira, et al. 1998 C-reactive protein as an indicator of sepsis Intensive Care Med 24 1052 1056 9840239 10.1007/ s001340050715 1:STN:280:DyaK1M%2Fltl2ktg%3D%3D (Pubitemid 28497823)
46. B Uzzan R Cohen P Nicolas M Cucherat GY Perret 2006 Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis Crit Care Med 37 7 1996 2003 10.1097/01.CCM.0000226413.54364.36 (Pubitemid 43982479)
47. L Simon F Gauvin DK Amre P Saint-Louis J Lacroix 2004 Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Clin Infect Dis 39 206 217 15307030 10.1086/421997 1:CAS:528:DC%2BD2cXmslGqu7k%3D (Pubitemid 38971491)
48. Wolff M, Bouadma L (2010) What procalcitonin brings to management of sepsis in the ICU. Crit Care 14(6):1007 (epub 2010)
49. Tang H, Huang T, Jing J, Shen H, Cui W (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 37(6):497-507 (epub 2009)
50. FA Bozza JI Salluh AM Japiassu, et al. 2007 Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis Crit Care 11 R49 17448250 10.1186/cc5783 (Pubitemid 46805280)
51. NI Shapiro S Trzeciak JE Hollander, et al. 2009 A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis Crit Care Med 37 96 104 19050610 10.1097/CCM.0b013e318192fd9d
52. Marshall JC, Reinhart K, for the International Sepsis Forum (2009) Biomarkers of sepsis. Crit Care Med 37(7):2290-2298